Loading...
Pain Care Labs, the industry leader in non-invasive, drug-free pain solutions, has been selected to present its proprietary mechanical stimulation external neuromodulation pain relief technology at both the National Institutes of Health (NIH) Innovation Conference (NIC) and next week’s virtual Life Sciences Summit (LSS).
“We’re honored to be selected as an Emerging Technology Company to both gain valuable feedback from the mentors at NIC, and to find partners with aligned goals at the Life Sciences Summit,” said Amy Baxter M.D., CEO and Chief Medical Officer of Pain Care Labs. “Our presentation is not just about our company, but a deep dive on a new understanding of pain and neural networks, and how specific frequencies, thermal interventions, and patient empowerment have blocked pain and reduced or eliminated pharmaceutical use for everything from knee surgeries to needles.”
During the half-day, invitation-only NIC, Dr. Baxter and Pain Care Labs' Director of Channel Marketing & Business Development, Nicole O’Brien, presented to NIH representatives, life science investors, and industry executives who mentored in advance and gave live feedback in preparation for the LSS. The Summit is an early-stage investor and business development conference for emerging companies and academic innovators. The objective of the meeting is to connect emerging companies with early-stage investors, business development professionals, strategic industry partners, and medical research foundations. The Pain Care Labs presentation at the virtual LSS is Tuesday, Nov. 17 at 11:00 a.m. Pain Care Labs is not seeking investment, but established partners with distribution channels in the verticals of consumer, post-operative, and injectable or biologics adherence.
Pain Care Labs (a dba of MMJ Labs) was established in 2006 by pediatric emergency physician and pain researcher Amy Baxter. Her NIH funding led to the discovery of widespread needle fear, the critical components of pain, and an entire new platform for natural effective pain relief. Now she and her amazing team are out to change the world and eliminate unnecessary pain. The frequency Dr. Baxter used to create Buzzy® is now proven to inhibit pain better than TENS, improve muscle soreness, blood flow, recovery and more. With multiple patents and FDA 510(k) clearances to control and treat pain, the company created the VibraCool®. VibraCool’s M-Stim® pain relief was 2-3.4 times superior to electrical stimulation (TENS) for physical therapy; another demonstrated 35% fewer opioid tablets after knee surgery.